Logo

Compugen Announces Addition of Two Proteins to Pipeline

Jun 07, 2004

NEW YORK, June 7 (GenomeWeb News) - Compugen said today that it has recently added two novel therapeutic proteins, identified using the company's discovery engines, to its research pipeline.

 

According to the company, the proteins are CGEN M-3, a soluble kinase receptor with potential applications in cancer, and CGEN P-4, a peptide that may be useful in the areas of obesity and eating disorders.

 

The proteins, said Compugen, were initially predicted in-silico and are now being evaluated in the company's molecular biology labs.

 

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.